Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975
Medication labelWhy this: Advisory · dailymed-prescription
Carbidopa and levodopa extended-release capsules are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
- generic_name
- carbidopa and levodopa
- product_names
- Carbidopa and Levodopa
- ndc
- 70518-4610, 70710-2142, 70518-4610-1, 70518-4610-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en